Jean‐Charles Fruchart

Risk Engineering (Bulgaria) ·

Area of research

Surgery · Molecular Biology

Research interest

Research interests include Peroxisome Proliferator-Activated Receptors, Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health, and Cholesterol and Lipid Metabolism.

h-index

104

citations

39,924

works

471

NIH funding

—

primary concept

Medicine

✉ Find email ↗

Recent publications

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

New England Journal of Medicine 2022cited by 693position: middledoi

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential

Cardiovascular Diabetology 2019cited by 142position: firstdoi

Residual macrovascular risk in 2013: what have we learned?

Cardiovascular Diabetology 2014cited by 170position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.